Prof. Daniel Carr Tufts University School of Medicine and Javelin Pharmaceuticals, USA

Daniel Carr is an Honorary Member of the International Association for the Study or Pain (IASP), and Professor Emeritus at Tufts University. He has had leadership roles in multiple pain-related professional organizations including the American Academy of Pain Medicine and American Society of Anesthesiologists. He has published extensively on acute,... read morechronic and cancer-related pain, pain research and education, evidence-based pain medicine, clinical practice and the social aspects of pain. He holds dozens of patents related to medicinal chemistry and has participated in varied USFDA meetings. From 2004 to 2010 he was CMO for Javelin Pharmaceuticals until its acquisition by Hospira (then Pfizer).

He has served on multiple editorial and advisory boards including Massachusetts’ Governor’s Medical Education Working Group on Prescription Drug Misuse, Mass DPH’s Drug Formulary Commission, the US National Pain Strategy, the Federal Trade Commission, the National Academy of Medicine, and presently, NIH’s Interagency Pain Research Coordinating Committee. His most recent book, Pain After Surgery, was published by IASP in 2019.